2024. In Vivo Evaluation of Anti-Inflammatory Activity of Quinoxaline Derivatives Using Carrageenan-Induced Rat Paw Edema Model. International Journal of Pharmacy and Life Sciences. 15, 11 (Nov. 2024), 9–15.